D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 73 Citations 14,666 225 World Ranking 3814 National Ranking 1940

Overview

What is he best known for?

The fields of study Thomas E. Eling is best known for:

  • Gene
  • Enzyme
  • Cancer

Arachidonic acid, Cyclooxygenase and ATP synthase are the main areas of his Enzyme studies. He undertakes interdisciplinary study in the fields of Biochemistry and Immunology through his works. Thomas E. Eling conducts interdisciplinary study in the fields of Immunology and Biochemistry through his research. Thomas E. Eling combines Gene and Prostaglandin in his research. He integrates Prostaglandin and Gene in his research. In his research, Thomas E. Eling performs multidisciplinary study on Cancer research and Carcinogenesis. He integrates Carcinogenesis with Cancer research in his research. Many of his studies on Pharmacology apply to Sulindac as well. As part of his studies on Sulindac, Thomas E. Eling often connects relevant subjects like Nonsteroidal.

His most cited work include:

  • The horseradish peroxidase-catalyzed oxidation of 3,5,3',5'-tetramethylbenzidine. Free radical and charge-transfer complex intermediates. (749 citations)
  • High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin (730 citations)
  • Cyclooxygenase Inhibitors Regulate the Expression of a TGF-β Superfamily Member That Has Proapoptotic and Antitumorigenic Activities (362 citations)

What are the main themes of his work throughout his whole career to date

In his papers, Thomas E. Eling integrates diverse fields, such as Biochemistry and Immunology. He integrates Immunology with Biochemistry in his research. While working in this field, he studies both Enzyme and Peroxidase. Thomas E. Eling undertakes multidisciplinary studies into Gene and Cell biology in his work. Thomas E. Eling integrates many fields, such as Cell biology and Molecular biology, in his works. Thomas E. Eling performs integrative study on Molecular biology and Gene expression in his works. He connects Gene expression with Gene in his research. He merges many fields, such as Internal medicine and Endocrinology, in his writings. His work often combines Endocrinology and Internal medicine studies.

Thomas E. Eling most often published in these fields:

  • Biochemistry (85.71%)
  • Enzyme (58.93%)
  • Gene (33.04%)

What were the highlights of his more recent work (between 2011-2022)?

  • Internal medicine (68.75%)
  • Biochemistry (56.25%)
  • Endocrinology (56.25%)

In recent works Thomas E. Eling was focusing on the following fields of study:

A significant part of his Cancer research incorporates Carcinogenesis, Colorectal cancer and Prostate cancer studies. His Cancer research extends to Carcinogenesis, which is thematically connected. Thomas E. Eling undertakes interdisciplinary study in the fields of Colorectal cancer and Cancer research through his research. He connects Cancer research with Prostate cancer in his study. His Internal medicine study frequently draws connections to other fields, such as Receptor. Many of his studies on Receptor apply to Internal medicine as well. His Biochemistry study often links to related topics such as Biomarker. His work on Leptin expands to the thematically related Endocrinology. Thomas E. Eling integrates Leptin and Adipose tissue in his research.

Between 2011 and 2022, his most popular works were:

  • NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism (160 citations)
  • The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer (116 citations)
  • Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases (89 citations)

In his most recent research, the most cited works focused on:

  • Gene
  • Cancer
  • Enzyme

His study on Internal medicine is mostly dedicated to connecting different topics, such as Transforming growth factor. While working on this project, Thomas E. Eling studies both Transforming growth factor and Cancer. He performs integrative study on Cancer and Cancer research in his works. By researching both Cancer research and Prostate cancer, Thomas E. Eling produces research that crosses academic boundaries. While working in this field, Thomas E. Eling studies both Prostate cancer and Colorectal cancer. His multidisciplinary approach integrates Colorectal cancer and Pancreatic cancer in his work. His research ties Internal medicine and Pancreatic cancer together. His study ties his expertise on Apoptosis together with the subject of Biochemistry. In most of his Apoptosis studies, his work intersects topics such as Biochemistry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The horseradish peroxidase-catalyzed oxidation of 3,5,3',5'-tetramethylbenzidine. Free radical and charge-transfer complex intermediates.

P D Josephy;T Eling;R P Mason.
Journal of Biological Chemistry (1982)

966 Citations

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.

Toshihiko Tanno;Natarajan V Bhanu;Patricia A Oneal;Sung-Ho Goh.
Nature Medicine (2007)

963 Citations

Prostaglandin H synthase and xenobiotic oxidation.

T E Eling;D C Thompson;G L Foureman;J F Curtis.
Annual Review of Pharmacology and Toxicology (1990)

388 Citations

Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia.

Tongguang Wang;Liya Qin;Bin Liu;Yuxin Liu.
Journal of Neurochemistry (2004)

296 Citations

Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53

Seung Joon Baek;Leigh C. Wilson;Thomas E. Eling.
Carcinogenesis (2002)

243 Citations

Cyclooxygenase Inhibitors Induce the Expression of the Tumor Suppressor Gene EGR-1, Which Results in the Up-Regulation of NAG-1, an Antitumorigenic Protein

Seung Joon Baek;Jong-Sik Kim;Scott M Moore;Seong-Ho Lee.
Molecular Pharmacology (2005)

202 Citations

Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells.

Seung Joon Baek;Jong-Sik Kim;Felix R. Jackson;Thomas E. Eling.
Carcinogenesis (2004)

190 Citations

Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts. Differential effects in tumor suppressor gene (+) and (-) phenotypes.

W.C. Glasgow;C.A. Afshari;J.C. Barrett;T.E. Eling.
Journal of Biological Chemistry (1992)

183 Citations

Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1 Over Expression in Transgenic Mice Suppresses Intestinal Neoplasia

Seung Joon Baek;Ryuji Okazaki;Seong-Ho Lee;Jeanelle Martinez.
Gastroenterology (2006)

180 Citations

Mitogenic signaling by epidermal growth factor (EGF), but not platelet-derived growth factor, requires arachidonic acid metabolism in BALB/c 3T3 cells : modulation of EGF-dependent c-myc expression by prostaglandins

J A Handler;R M Danilowicz;T E Eling.
Journal of Biological Chemistry (1990)

178 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas E. Eling

Lawrence J. Marnett

Lawrence J. Marnett

Vanderbilt University

Publications: 87

Seung Joon Baek

Seung Joon Baek

Seoul National University

Publications: 64

Ronald P. Mason

Ronald P. Mason

National Institutes of Health

Publications: 50

George Psomas

George Psomas

Aristotle University of Thessaloniki

Publications: 29

Marie Stiborová

Marie Stiborová

Charles University

Publications: 28

Tomas Ganz

Tomas Ganz

University of California, Los Angeles

Publications: 27

Samuel N. Breit

Samuel N. Breit

University of New South Wales

Publications: 27

David A. Brown

David A. Brown

University of Sydney

Publications: 27

Stefano Rivella

Stefano Rivella

Children's Hospital of Philadelphia

Publications: 27

Eva Frei

Eva Frei

Charles University

Publications: 23

Elizabeta Nemeth

Elizabeta Nemeth

University of California, Los Angeles

Publications: 21

Valerian E. Kagan

Valerian E. Kagan

University of Pittsburgh

Publications: 20

Ah-Lim Tsai

Ah-Lim Tsai

The University of Texas at Austin

Publications: 20

Andrew J. Dannenberg

Andrew J. Dannenberg

Cornell University

Publications: 20

Dorine W. Swinkels

Dorine W. Swinkels

Radboud University Nijmegen

Publications: 20

Kenneth V. Honn

Kenneth V. Honn

Wayne State University

Publications: 20

Trending Scientists

Yang Xiang

Yang Xiang

Swinburne University of Technology

Matthai Philipose

Matthai Philipose

Microsoft (United States)

Fan Ye

Fan Ye

Stony Brook University

André De Cian

André De Cian

Centre national de la recherche scientifique, CNRS

Sakamon Devahastin

Sakamon Devahastin

King Mongkut's University of Technology Thonburi

Philippe Renaud

Philippe Renaud

École Polytechnique Fédérale de Lausanne

David A. Wink

David A. Wink

National Institutes of Health

Lihua Wang

Lihua Wang

Chinese Academy of Sciences

Ashley T. Haase

Ashley T. Haase

University of Minnesota

Nicola Carslaw

Nicola Carslaw

University of York

Janine I. Rossato

Janine I. Rossato

Federal University of Rio Grande do Norte

Ronald L. Hayes

Ronald L. Hayes

The University of Texas Health Science Center at Houston

Thomas Bugnyar

Thomas Bugnyar

University of Vienna

George J. Brewer

George J. Brewer

University of Michigan–Ann Arbor

Patrick M. Catalano

Patrick M. Catalano

Case Western Reserve University

Neal Halfon

Neal Halfon

University of California, Los Angeles

Something went wrong. Please try again later.